Related Experiment Video

Updated: Jul 7, 2026

Monitoring Changes in Human Umbilical Vein Endothelial Cells upon Viral Infection Using Impedance-Based Real-Time Cell Analysis
07:56

Monitoring Changes in Human Umbilical Vein Endothelial Cells upon Viral Infection Using Impedance-Based Real-Time Cell Analysis

Published on: May 5, 2023

[Simvastatin downregulates CD40L induced vascular cell adhesion molecule-1 expression and adhesive function in human

Min Zhang1, Wei-Yi Fang, Fang Yuan

  • 1Department of Cardiology, Chest Hospital, Shanghai Jiaotong University, Shanghai 200030, China.

Zhonghua Xin Xue Guan Bing Za Zhi
|February 14, 2008
PubMed

Insights

Simvastatin reduces vascular cell adhesion molecule-1 (VCAM-1) expression and lymphocyte adhesion to endothelial cells. This effect, observed in CD40L-treated cells, highlights simvastatin's potential in managing vascular inflammation.

Area of Science:

  • Endothelial cell biology
  • Molecular immunology
  • Pharmacology

Context:

  • CD40L induces vascular cell adhesion molecule-1 (VCAM-1) expression in endothelial cells.
  • VCAM-1 plays a critical role in lymphocyte adhesion and inflammatory responses.
  • Simvastatin is a statin drug with pleiotropic effects beyond lipid-lowering.

Purpose:

  • To investigate the impact of simvastatin on CD40L-induced VCAM-1 expression.
  • To assess simvastatin's effect on lymphocyte adhesion to endothelial cells.

Summary:

  • Simvastatin significantly decreased CD40L-induced VCAM-1 expression in a dose-dependent manner.
  • The inhibitory effect of simvastatin was reversible by mevalonic acid.
  • Simvastatin treatment markedly reduced lymphocyte adhesion to CD40L-stimulated endothelial cells.

Impact:

  • Simvastatin downregulates VCAM-1 expression and reduces endothelial cell adhesion capacity.
  • Findings suggest simvastatin may have therapeutic potential in inflammatory vascular conditions.
Abstract

More Related Videos

On-Chip Endothelial Inflammatory Phenotyping12:43

On-Chip Endothelial Inflammatory Phenotyping

Published on: July 21, 2012

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...